177 related articles for article (PubMed ID: 35902730)
1. CYP2E1-dependent upregulation of SIRT7 is response to alcohol mediated metastasis in hepatocellular carcinoma.
Zhang C; Zhao J; Zhao J; Liu B; Tang W; Liu Y; Huang W; Weinman SA; Li Z
Cancer Gene Ther; 2022 Dec; 29(12):1961-1974. PubMed ID: 35902730
[TBL] [Abstract][Full Text] [Related]
2. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
Zhao J; Wozniak A; Adams A; Cox J; Vittal A; Voss J; Bridges B; Weinman SA; Li Z
J Exp Clin Cancer Res; 2019 Jun; 38(1):252. PubMed ID: 31196136
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin6 (SIRT6) Promotes the EMT of Hepatocellular Carcinoma by Stimulating Autophagic Degradation of E-Cadherin.
Han LL; Jia L; Wu F; Huang C
Mol Cancer Res; 2019 Nov; 17(11):2267-2280. PubMed ID: 31551254
[TBL] [Abstract][Full Text] [Related]
4. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
5. SIRT7 promotes Hippo/YAP activation and cancer cell proliferation in hepatocellular carcinoma via suppressing MST1.
Gu Y; Ding C; Yu T; Liu B; Tang W; Wang Z; Tang X; Liang G; Peng J; Zhang X; Li Z
Cancer Sci; 2024 Apr; 115(4):1209-1223. PubMed ID: 38288904
[TBL] [Abstract][Full Text] [Related]
6. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW
Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745
[TBL] [Abstract][Full Text] [Related]
7. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and molecular analysis of SIRT7 in hepatocellular carcinoma.
Yanai M; Kurata M; Muto Y; Iha H; Kanao T; Tatsuzawa A; Ishibashi S; Ikeda M; Kitagawa M; Yamamoto K
Pathology; 2020 Aug; 52(5):529-537. PubMed ID: 32586688
[TBL] [Abstract][Full Text] [Related]
9. SIRT7 interacts with TEK (TIE2) to promote adriamycin induced metastasis in breast cancer.
Yang F; Hu Y; Shao L; Zhuang J; Huo Q; He S; Chen S; Wang J; Xie N
Cell Oncol (Dordr); 2021 Dec; 44(6):1405-1424. PubMed ID: 34797559
[TBL] [Abstract][Full Text] [Related]
10. SIRT7 suppresses the epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis by promoting SMAD4 deacetylation.
Li W; Zhu D; Qin S
J Exp Clin Cancer Res; 2018 Jul; 37(1):148. PubMed ID: 30001742
[TBL] [Abstract][Full Text] [Related]
11. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Zhou W; Gong L; Wu Q; Xing C; Wei B; Chen T; Zhou Y; Yin S; Jiang B; Xie H; Zhou L; Zheng S
J Exp Clin Cancer Res; 2018 Sep; 37(1):215. PubMed ID: 30180906
[TBL] [Abstract][Full Text] [Related]
12. RARγ-induced E-cadherin downregulation promotes hepatocellular carcinoma invasion and metastasis.
Gan WJ; Wang JR; Zhu XL; He XS; Guo PD; Zhang S; Li XM; Li JM; Wu H
J Exp Clin Cancer Res; 2016 Oct; 35(1):164. PubMed ID: 27756432
[TBL] [Abstract][Full Text] [Related]
13. 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.
Liu TA; Jan YJ; Ko BS; Liang SM; Chen SC; Wang J; Hsu C; Wu YM; Liou JY
PLoS One; 2013; 8(3):e57968. PubMed ID: 23483955
[TBL] [Abstract][Full Text] [Related]
14. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma.
Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J
J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929
[TBL] [Abstract][Full Text] [Related]
15. LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression.
Xu X; Gu J; Ding X; Ge G; Zang X; Ji R; Shao M; Mao Z; Zhang Y; Zhang J; Mao F; Qian H; Xu W; Cai H; Wang F; Zhang X
Cell Death Dis; 2019 Oct; 10(10):752. PubMed ID: 31582742
[TBL] [Abstract][Full Text] [Related]
16. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
17. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
18. TNF-α/NF-κB signaling epigenetically represses PSD4 transcription to promote alcohol-related hepatocellular carcinoma progression.
Shi J; Song S; Li S; Zhang K; Lan Y; Li Y
Cancer Med; 2021 May; 10(10):3346-3357. PubMed ID: 33932127
[TBL] [Abstract][Full Text] [Related]
19. CYP2E1 plays a suppressive role in hepatocellular carcinoma by regulating Wnt/Dvl2/β-catenin signaling.
Zhu L; Yang X; Feng J; Mao J; Zhang Q; He M; Mi Y; Mei Y; Jin G; Zhang H
J Transl Med; 2022 May; 20(1):194. PubMed ID: 35509083
[TBL] [Abstract][Full Text] [Related]
20. Sirtuin7 has an oncogenic potential via promoting the growth of cholangiocarcinoma cells.
Li W; Sun Z; Chen C; Wang L; Geng Z; Tao J
Biomed Pharmacother; 2018 Apr; 100():257-266. PubMed ID: 29438839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
